Trial Profile
A trial evaluating the clinical response to vedolizumab and the relationship with vitamine D levels in patients with inflammatory-bowel-diseases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 27 Feb 2016 New trial record